4.0 Review

Chronic Inflammatory Demyelinating Polyneuropathy

Journal

CURRENT TREATMENT OPTIONS IN NEUROLOGY
Volume 15, Issue 3, Pages 350-366

Publisher

CURRENT MEDICINE GROUP
DOI: 10.1007/s11940-013-0229-6

Keywords

Chronic inflammatory demyelinating polyneuropathy; CIDP; MADSAM; MMN; DADS; Epidemiology; Clinical manifestation; Nerve conduction studies; Pathogenesis; Treatment; Plasmapheresis; IVIg; Corticosteroids; Prognosis

Funding

  1. NCATS NIH HHS [UL1 TR000001] Funding Source: Medline

Ask authors/readers for more resources

Chronic Inflammatory polyneuropathies are an important group of neuromuscular disorders that present chronically and progress over more than 8 weeks, being referred to as chronic inflammatory demyelinating polyneuropathy (CIDP). Despite tremendous progress in elucidating disease pathogenesis, the exact triggering event remains unknown. Our knowledge regarding diagnosis and management of CIDP and its variants continues to expand, resulting in improved opportunities for identification and treatment. Most clinical neurologists will be involved in the management of patients with these disorders, and should be familiar with available therapies for CIDP. We review the distinctive clinical, laboratory, and electro-diagnostic features that aid in diagnosis. We emphasize the importance of clinical patterns that define treatment responsiveness and the most appropriate therapies in order to improve prognosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available